Shaman

Impatient Health's #Pharmageddon Europe is coming. Starting on 𝗦𝗲𝗽𝘁𝗲𝗺𝗯𝗲𝗿 𝟮𝟱𝘁𝗵 𝟮𝟬𝟮𝟰 𝗶𝗻 𝗔𝗺𝘀𝘁𝗲𝗿𝗱𝗮𝗺, disruptors and innovators from all over Europe will gather to share ideas to drive innovation in Pharma and shake up a sector that can be so closed. Of course, Shaman looks forward to roll up her sleeves and spread the word about the immense 𝗽𝗿𝗼𝗯𝗹𝗲𝗺-𝘀𝗼𝗹𝘃𝗶𝗻𝗴 𝗽𝗼𝘄𝗲𝗿 𝗼𝗳 𝘁𝗲𝗰𝗵 𝗶𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 𝗳𝗼𝗿 𝗣𝗵𝗮𝗿𝗺𝗮 𝗦𝗮𝗹𝗲𝘀 𝗮𝗻𝗱 𝗠𝗮𝗿𝗸𝗲𝘁𝗶𝗻𝗴; about the vision that we share with our Global Pharma customers who have embraced digital innovation, who thrive and who gain a competitive edge by doing things better and faster. We will share our observations of Pharma marketing leaders who have beaten the treadmill of pushing communications to their HCP network, who have re-thought their content creation, distribution and management, who are more successful in making an impact within their networks. Join us, in just over a month, at #pharmageddon in Amsterdam. 𝗟𝗲𝘁’𝘀 𝗿𝗲-𝗶𝗺𝗮𝗴𝗶𝗻𝗲 𝗲𝗻𝗱-𝘁𝗼-𝗲𝗻𝗱 𝗺𝗮𝗿𝗸𝗲𝘁𝗶𝗻𝗴 𝗰𝗼𝗻𝘁𝗲𝗻𝘁 𝗰𝗿𝗲𝗮𝘁𝗶𝗼𝗻 𝗮𝗻𝗱 𝗱𝗶𝘀𝘁𝗿𝗶𝗯𝘂𝘁𝗶𝗼𝗻 - 𝘁𝗼𝗴𝗲𝘁𝗵𝗲𝗿!

𝗙𝗶𝗴𝗵𝘁𝗶𝗻𝗴 𝘁𝗵𝗲 𝗪𝗮𝘀𝘁𝗲 𝗼𝗳 𝗪𝗮𝗶𝘁𝗶𝗻𝗴 On the quest for 𝗔𝗴𝗶𝗹𝗲 𝗠𝗮𝗿𝗸𝗲𝘁𝗶𝗻𝗴 success, our Global Pharma marketing customers scrutinize metrics such as 𝗣𝗿𝗼𝗱𝘂𝗰𝘁𝗶𝗼𝗻 𝗘𝗳𝗳𝗶𝗰𝗶𝗲𝗻𝗰𝘆, 𝗣𝗿𝗼𝗱𝘂𝗰𝘁𝗶𝗼𝗻 𝗖𝘆𝗰𝗹𝗲 𝗧𝗶𝗺𝗲 𝗮𝗻𝗱 𝗧𝗵𝗿𝗼𝘂𝗴𝗵𝗽𝘂𝘁. These are all excellent starting points for marketeers to improve their outputs. 𝗦𝗺𝗮𝗿𝘁 𝗺𝗮𝗿𝗸𝗲𝘁𝗲𝗲𝗿𝘀 𝗸𝗻𝗼𝘄 𝘁𝗵𝗮𝘁 𝗼𝘂𝘁𝗽𝘂𝘁𝘀 𝗮𝗿𝗲 𝗷𝘂𝘀𝘁 𝗮𝗻 𝗶𝗻𝘁𝗲𝗿𝗺𝗲𝗱𝗶𝗮𝘁𝗲 𝗴𝗼𝗮𝗹: 𝗶𝘁’𝘀 𝗽𝗼𝘀𝗶𝘁𝗶𝘃𝗲 𝗯𝘂𝘀𝗶𝗻𝗲𝘀𝘀 𝗼𝘂𝘁𝗰𝗼𝗺𝗲𝘀 𝘁𝗵𝗮𝘁 𝘁𝗵𝗲𝘆 𝗮𝗿𝗲 𝗿𝗲𝗮𝗹𝗹𝘆 𝗮𝗳𝘁𝗲𝗿. But how to prioritize your backlog as a Pharma marketeer in such a way that you deliver these solid business outcomes? In a world with limited marketing resources and conflicting priorities, where stakeholders want it all and want it yesterday, how can you do the right work at the right time? 𝗟𝗲𝘁’𝘀 𝗵𝗮𝘃𝗲 𝗮 𝗹𝗼𝗼𝗸 𝗮𝘁 𝗮 𝗻𝗲𝘄 𝗺𝗲𝘁𝗿𝗶𝗰: 𝗧𝗵𝗲 𝗖𝗼𝘀𝘁-𝗼𝗳-𝗗𝗲𝗹𝗮𝘆 (𝗖𝗼𝗗) Cycle Time is a useful metric, but it’s a measure of speed, not agility and by all means a lagging indicator. Don Reinertsen, an Agile Thought leader argues that if you want to get the maximum business value from a given size marketing team, you should focus on the work items with the highest value of urgency (or Cost of Delay). Analyzing Cost of Delay is important because it focuses on the business value of marketing; understanding it is essential if you want to maximize the value of marketing. With a CoD metric we’re putting a price tag on time: how much money you lose (per unit of time) due to a delay in launching your marketing campaign. 𝗛𝗼𝘄 𝘁𝗼 𝗰𝗮𝗹𝗰𝘂𝗹𝗮𝘁𝗲 𝗶𝘁? We will not delve into exact formulas here, but the good news is that you don’t need to be able to precisely predict the cost of delay in order to make better and more strategic decisions by using it. The mere practice of estimating Cost of Delay is a catalyst for important conversations that wouldn’t otherwise happen if the focus is merely on ‘production speed’ and not ‘the Waste of Waiting’. 𝗔𝗿𝗲 𝘆𝗼𝘂 𝗰𝘂𝗿𝗶𝗼𝘂𝘀 𝗮𝗯𝗼𝘂𝘁 𝗵𝗼𝘄 𝗦𝗵𝗮𝗺𝗮𝗻 𝗰𝗮𝗻 𝗵𝗲𝗹𝗽 𝘆𝗼𝘂𝗿 𝘁𝗼 𝗲𝗹𝗶𝗺𝗶𝗻𝗮𝘁𝗲 𝘁𝗵𝗲 𝗪𝗮𝘀𝘁𝗲-𝗼𝗳-𝗪𝗮𝗶𝘁𝗶𝗻𝗴? 𝗢𝘂𝗿 𝗰𝗼𝗻𝘀𝘂𝗹𝘁𝗮𝗻𝘁𝘀 𝗮𝗿𝗲 𝗵𝗮𝗽𝗽𝘆 𝘁𝗼 𝗲𝘅𝗽𝗹𝗮𝗶𝗻 𝗵𝗼𝘄 𝘆𝗼𝘂 𝗰𝗮𝗻 𝗶𝗺𝗽𝗿𝗼𝘃𝗲 𝘆𝗼𝘂𝗿 𝗯𝘂𝘀𝗶𝗻𝗲𝘀𝘀 𝗼𝘂𝘁𝗰𝗼𝗺𝗲𝘀 𝘄𝗶𝘁𝗵 𝗖𝗼𝗻𝘁𝗲𝗻𝘁 𝗣𝗿𝗼𝗱𝘂𝗰𝘁𝗶𝗼𝗻 𝗶𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻. Have great Friday! Team Shaman

At Shaman, we are proud to have Merz Therapeutics as Partner. We support Merz Therapeutics in innovating its global marketing content production, making it more agile, efficient, and cost-effective. We thank Matthias Keil and his team for their ongoing trust in Shaman Content Excellence Solutions; the eDetail (CLM) and RTE Builders as well as Shaman Hub for multi-country content sharing.

𝐃𝐨 𝐰𝐞 𝐚𝐠𝐫𝐞𝐞 𝐭𝐡𝐚𝐭 𝐭𝐡𝐞 𝐬𝐮𝐜𝐜𝐞𝐬𝐬 𝐨𝐟 𝐲𝐨𝐮𝐫 𝐬𝐚𝐥𝐞𝐬 𝐞𝐟𝐟𝐨𝐫𝐭𝐬 𝐫𝐞𝐥𝐢𝐞𝐬 𝐨𝐧 𝐭𝐡𝐞 𝐪𝐮𝐚𝐥𝐢𝐭𝐲, 𝐫𝐞𝐥𝐞𝐯𝐚𝐧𝐜𝐞 𝐚𝐧𝐝 𝐝𝐞𝐥𝐢𝐯𝐞𝐫𝐚𝐛𝐢𝐥𝐢𝐭𝐲 𝐨𝐟 𝐲𝐨𝐮𝐫 𝐜𝐨𝐧𝐭𝐞𝐧𝐭? The right Content Authoring Solution (CAS) can have a profound impact on the content your produce - and your organisation's success. Discover how to transform your content production workfows for Veeva by picking the right authoring tool. Download the Shaman guide “𝐂𝐡𝐨𝐨𝐬𝐢𝐧𝐠 𝐓𝐡𝐞 𝐑𝐢𝐠𝐡𝐭 𝐕𝐞𝐞𝐯𝐚 𝐀𝐮𝐭𝐡𝐨𝐫𝐢𝐧𝐠 𝐓𝐨𝐨𝐥” and read about: - Drawbacks of your current content creation strategy; - Step-by-step criteria to pick the right authoring tool; - The numerous organisational benefts of switching. You can download our guide here: https://bit.ly/ShamanCAT

𝗧𝗵𝗲 𝗙𝘂𝘁𝘂𝗿𝗲 𝗼𝗳 𝗢𝗺𝗻𝗶𝗰𝗵𝗮𝗻𝗻𝗲𝗹 𝗠𝗮𝗿𝗸𝗲𝘁𝗶𝗻𝗴 𝗶𝗻 𝗣𝗵𝗮𝗿𝗺𝗮 𝗶𝘀 𝗻𝗼𝘄 We're on the brink of a new era in omnichannel marketing for pharma, where emerging trends and technologies promise to revolutionize the industry. Key advancements like generative artificial intelligence (𝗚𝗲𝗻𝗔𝗜) and natural language processing (NLP) will transform how pharmaceutical companies understand and predict customer behaviors. 𝗧𝗵𝗶𝘀 𝗺𝗲𝗮𝗻𝘀 𝗺𝗼𝗿𝗲 𝗽𝗿𝗲𝗰𝗶𝘀𝗲, 𝘁𝗮𝗿𝗴𝗲𝘁𝗲𝗱 𝗰𝗼𝗺𝗺𝘂𝗻𝗶𝗰𝗮𝘁𝗶𝗼𝗻𝘀 𝗮𝗻𝗱 𝘀𝘁𝗿𝗲𝗮𝗺𝗹𝗶𝗻𝗲𝗱 𝗽𝗿𝗼𝗰𝗲𝘀𝘀𝗲𝘀, 𝗲𝗻𝗮𝗯𝗹𝗶𝗻𝗴 𝗳𝗮𝘀𝘁𝗲𝗿 𝗰𝗼𝗻𝘁𝗲𝗻𝘁 𝗰𝗿𝗲𝗮𝘁𝗶𝗼𝗻 𝗮𝗻𝗱 𝘀𝘁𝗿𝗮𝘁𝗲𝗴𝘆 𝗱𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁, 𝗿𝗲𝘀𝘂𝗹𝘁𝗶𝗻𝗴 𝗶𝗻 𝗺𝗼𝗿𝗲 𝘀𝗮𝘁𝗶𝘀𝗳𝗶𝗲𝗱 𝗰𝘂𝘀𝘁𝗼𝗺𝗲𝗿𝘀 𝗮𝗻𝗱 𝗵𝗶𝗴𝗵𝗲𝗿 𝗛𝗖𝗣 𝗮𝗱𝗼𝗽𝘁𝗶𝗼𝗻. With evolving customer expectations, 𝗽𝗲𝗿𝘀𝗼𝗻𝗮𝗹𝗶𝘇𝗮𝘁𝗶𝗼𝗻 has become a necessity rather than a luxury. Companies must now focus on crafting unique, individualized experiences at every touchpoint. Start integrating these cutting-edge trends into your strategy and deliver exceptional, personalized customer experiences. 👉 Curious how Shaman can help you do this most effectively and efficiently? Let's connect! #PharmaMarketing #Omnichannel #AI #Personalization #DigitalTransformation

At Shaman, we see that to keep pace, Pharma marketing teams are creating more content.  This content is piling up fast, which poses a problem. Faced with tight budgets, long review cycles (which can take up to weeks), and outsourcing delays, content is getting stuck in the pipeline. And then it’s going to waste. Why not work smarter, not harder? Do you have the ambition to create a razor-sharp production workflow that doesn’t just churn the content mill but lets you localize and reuse high-value assets for markets all over the world? Let’s talk and have us demonstrate our Multi-country Content Sharing solution that takes away language barriers and empowers content teams to share and reuse content…across the globe if needed. Enjoy your Friday and weekend!

𝗧𝗵𝗲 𝗙𝘂𝘁𝘂𝗿𝗲 𝗼𝗳 𝗣𝗵𝗮𝗿𝗺𝗮 𝗖𝗼𝗻𝘁𝗲𝗻𝘁 𝗖𝗿𝗲𝗮𝘁𝗶𝗼𝗻 𝗵𝗮𝘀 𝘀𝘁𝗮𝗿𝘁𝗲𝗱. 𝗗𝗶𝗱 𝘆𝗼𝘂 𝗻𝗼𝘁𝗶𝗰𝗲?🚀 We meet a lot of pharma leaders within the pharma content production chain who wonder “𝗪𝗵𝗮𝘁 𝗰𝗮𝗻 𝗚𝗲𝗻𝗔𝗜 𝗱𝗼?” Of course, this technological innovation seems full of promise. Many pharma companies have already established some sort of working group or task force to assess the phenomenon's value.  In a regulation-tight industry like pharma, the assessment becomes even more meaningful when it comes to the study of the security, privacy, and compliance aspects of AI. Let’s have a look at some highlights within a larger number of initial, often experimental use/cases within the content design, production, and approval steps in the production chain that lead to a faster time to market: -𝗙𝗮𝘀𝘁𝗲𝗿 𝗰𝗼𝗻𝘁𝗲𝗻𝘁 𝗽𝗿𝗼𝗱𝘂𝗰𝘁𝗶𝗼𝗻. AI can draft, revise and perfect scientific documents, marketing materials, and regular approvals in a fraction of the time. -𝗠𝗼𝗿𝗲 𝗰𝗼𝗺𝗽𝗹𝗶𝗮𝗻𝗰𝗲 𝗮𝗻𝗱 𝗰𝗼𝗻𝘀𝗶𝘀𝘁𝗲𝗻𝗰𝘆. With ever-evolving regulations, maintaining compliance can be daunting. AI can help to ensure consistency across all documents and versions. -𝗣𝗲𝗿𝘀𝗼𝗻𝗮𝗹𝗶𝘇𝗲𝗱 𝗖𝗼𝗺𝗺𝘂𝗻𝗶𝗰𝗮𝘁𝗶𝗼𝗻. AI helps you tailor your personalized communication to a segmented audience. You can imagine that especially in the more compliance-heavy parts of the content production cycle, the innovation is happening slower. It's foreseeable that when initial hurdles have been taken, the industry will move from toe-dipping into AI, to broader adoption of more task-oriented AI tooling when experiencing the undeniable benefits - of course, pharma-like, still with many layers of guarantees and supervision involved. AI will gain a foothold in all aspects of pharma marketing. So may we turn the question around? “𝗪𝗵𝗮𝘁 𝗮𝗿𝗲 𝘁𝗵𝗲 𝗯𝘂𝘀𝗶𝗻𝗲𝘀𝘀 𝗰𝗵𝗮𝗹𝗹𝗲𝗻𝗴𝗲𝘀 𝘁𝗵𝗮𝘁 𝘆𝗼𝘂’𝗱 𝗹𝗶𝗸𝗲 𝘁𝗼 𝘀𝗼𝗹𝘃𝗲?" The answer to that question will give you a better starting point in your AI discovery. Are you looking for more insights about the usability of AI in your role? Drop us a DM and let’s talk!

We are hiring! https://lnkd.in/eKypiXh5

Dear {{PharmaMarketer}}, This message is about {{𝗣𝗲𝗿𝘀𝗼𝗻𝗮𝗹𝗶𝘀𝗮𝘁𝗶𝗼𝗻}}. 70% of healthcare professionals (HCPs), our Global Pharma customers, have gone digital. Not only in their professional lives. Like you and me, they have become perceptive digital consumers that demand an outstanding digital experience. From the dimension of Pharma marketing and content production, this means that Global Pharma needs to adapt to these evolving content consumption habits and digital engagement patterns. To keep this short: In order to be relevant and make an impact, Pharma content must be tailored to the needs of the HCPs, prompting Global Pharma to make enormous efforts to personalize digital content. Many of the marketing leaders we speak to still struggle to grasp the full extent of what it means to personalize the customer experience and to understand the dramatic impact it can have on their marketing performance. These are the key questions they ask: 𝗖𝗼𝗻𝘁𝗲𝗻𝘁 𝘀𝘁𝗿𝗮𝘁𝗲𝗴𝘆: How do you build user profiles and journeys? 𝗖𝗼𝗻𝘁𝗲𝗻𝘁 𝗽𝗹𝗮𝗻𝗻𝗶𝗻𝗴: How do you map key messages across those journeys? 𝗖𝗼𝗻𝘁𝗲𝗻𝘁 𝗽𝗿𝗼𝗱𝘂𝗰𝘁𝗶𝗼𝗻: How do you develop content variants in an efficient way? 𝗖𝗼𝗻𝘁𝗲𝗻𝘁 𝗱𝗲𝗹𝗶𝘃𝗲𝗿𝘆: How do you get the right content in front of the right HCP? 𝗖𝗼𝗻𝘁𝗲𝗻𝘁 𝗮𝗻𝗮𝗹𝘆𝘁𝗶𝗰𝘀: How can I best tag and measure content in my tech ecosystem? 𝗧𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝘆: How can technology help me to do this at scale? At Shaman, we work together with our customers to help solve these questions. We have developed 4 unfailable content production strategies that help Global Pharma to increase marketing effectiveness and to drive adoption with personalisation across preferred downstream channels in the most agile, effective and efficient way possible. 𝗔𝗿𝗲 𝘆𝗼𝘂 𝗮𝗹𝗿𝗲𝗮𝗱𝘆 𝗹𝗼𝗼𝗸𝗶𝗻𝗴 𝗶𝗻𝘁𝗼 𝗵𝗼𝘄 𝘁𝗼 𝗮𝗱𝗼𝗽𝘁 𝗺𝗼𝗱𝘂𝗹𝗮𝗿 𝘄𝗼𝗿𝗸𝗳𝗹𝗼𝘄𝘀, 𝗼𝗿 𝘄𝗮𝘆𝘀 𝗼𝗳 𝗳𝗮𝘀𝘁 𝘁𝗿𝗮𝗰𝗸𝗶𝗻𝗴 𝘁𝗵𝗲 𝗠𝗟𝗥 𝗽𝗿𝗼𝗰𝗲𝘀𝘀? 𝗔𝗿𝗲 𝘆𝗼𝘂 𝘀𝗲𝗮𝗿𝗰𝗵𝗶𝗻𝗴 𝗳𝗼𝗿 𝗮 𝘀𝗼𝗹𝘂𝘁𝗶𝗼𝗻 𝘁𝗼 𝗵𝘆𝗽𝗲𝗿-𝗽𝗲𝗿𝘀𝗼𝗻𝗮𝗹𝗶𝘀𝗲 𝘆𝗼𝘂𝗿 𝗰𝗼𝗻𝘁𝗲𝗻𝘁 𝗶𝗻 𝗽𝗲𝗿𝗳𝗲𝗰𝘁 𝘀𝘆𝗻𝗰 𝘄𝗶𝘁𝗵 𝗩𝗲𝗲𝘃𝗮 𝗣𝗿𝗼𝗺𝗼𝗺𝗮𝘁𝘀 𝗮𝗻𝗱 𝗩𝗲𝗲𝘃𝗮 𝗖𝗥𝗠, 𝘁𝗼 𝘀𝗮𝘃𝗲 𝘂𝗽 𝘁𝗼 𝟴𝟬% 𝗼𝗳 𝘆𝗼𝘂𝗿 𝘁𝗶𝗺𝗲-𝘁𝗼-𝗺𝗮𝗿𝗸𝗲𝘁 𝗮𝗻𝗱 𝗽𝗿𝗼𝗱𝘂𝗰𝘁𝗶𝗼𝗻 𝗰𝗼𝘀𝘁𝘀? Just get in touch with us. {{𝗧𝗲𝗮𝗺 𝗦𝗵𝗮𝗺𝗮𝗻}}

Dear {{PharmaMarketer}}, This message is about {{𝗣𝗲𝗿𝘀𝗼𝗻𝗮𝗹𝗶𝘀𝗮𝘁𝗶𝗼𝗻}}. 70% of healthcare professionals (HCPs), our Global Pharma customers, have gone digital. Not only in their professional lives. Like you and me, they have become perceptive digital consumers that demand an outstanding digital experience. From the dimension of Pharma marketing and content production, this means that Global Pharma needs to adapt to these evolving content consumption habits and digital engagement patterns. To keep this short: In order to be relevant and make an impact, Pharma content must be tailored to the needs of the HCPs, prompting Global Pharma to make enormous efforts to personalize digital content. Many of the marketing leaders we speak to still struggle to grasp the full extent of what it means to personalize the customer experience and to understand the dramatic impact it can have on their marketing performance. These are the key questions they ask: 𝗖𝗼𝗻𝘁𝗲𝗻𝘁 𝘀𝘁𝗿𝗮𝘁𝗲𝗴𝘆: How do you build user profiles and journeys? 𝗖𝗼𝗻𝘁𝗲𝗻𝘁 𝗽𝗹𝗮𝗻𝗻𝗶𝗻𝗴: How do you map key messages across those journeys? 𝗖𝗼𝗻𝘁𝗲𝗻𝘁 𝗽𝗿𝗼𝗱𝘂𝗰𝘁𝗶𝗼𝗻: How do you develop content variants in an efficient way? 𝗖𝗼𝗻𝘁𝗲𝗻𝘁 𝗱𝗲𝗹𝗶𝘃𝗲𝗿𝘆: How do you get the right content in front of the right HCP? 𝗖𝗼𝗻𝘁𝗲𝗻𝘁 𝗮𝗻𝗮𝗹𝘆𝘁𝗶𝗰𝘀: How can I best tag and measure content in my tech ecosystem? 𝗧𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝘆: How can technology help me to do this at scale? At Shaman, we work together with our customers to help solve these questions. We have developed 4 unfailable content production strategies that help Global Pharma to increase marketing effectiveness and to drive adoption with personalisation across preferred downstream channels in the most agile, effective and efficient way possible. 𝗔𝗿𝗲 𝘆𝗼𝘂 𝗮𝗹𝗿𝗲𝗮𝗱𝘆 𝗹𝗼𝗼𝗸𝗶𝗻𝗴 𝗶𝗻𝘁𝗼 𝗵𝗼𝘄 𝘁𝗼 𝗮𝗱𝗼𝗽𝘁 𝗺𝗼𝗱𝘂𝗹𝗮𝗿 𝘄𝗼𝗿𝗸𝗳𝗹𝗼𝘄𝘀, 𝗼𝗿 𝘄𝗮𝘆𝘀 𝗼𝗳 𝗳𝗮𝘀𝘁 𝘁𝗿𝗮𝗰𝗸𝗶𝗻𝗴 𝘁𝗵𝗲 𝗠𝗟𝗥 𝗽𝗿𝗼𝗰𝗲𝘀𝘀? 𝗔𝗿𝗲 𝘆𝗼𝘂 𝘀𝗲𝗮𝗿𝗰𝗵𝗶𝗻𝗴 𝗳𝗼𝗿 𝗮 𝘀𝗼𝗹𝘂𝘁𝗶𝗼𝗻 𝘁𝗼 𝗵𝘆𝗽𝗲𝗿-𝗽𝗲𝗿𝘀𝗼𝗻𝗮𝗹𝗶𝘀𝗲 𝘆𝗼𝘂𝗿 𝗰𝗼𝗻𝘁𝗲𝗻𝘁 𝗶𝗻 𝗽𝗲𝗿𝗳𝗲𝗰𝘁 𝘀𝘆𝗻𝗰 𝘄𝗶𝘁𝗵 𝗩𝗲𝗲𝘃𝗮 𝗣𝗿𝗼𝗺𝗼𝗺𝗮𝘁𝘀 𝗮𝗻𝗱 𝗩𝗲𝗲𝘃𝗮 𝗖𝗥𝗠, 𝘁𝗼 𝘀𝗮𝘃𝗲 𝘂𝗽 𝘁𝗼 𝟴𝟬% 𝗼𝗳 𝘆𝗼𝘂𝗿 𝘁𝗶𝗺𝗲-𝘁𝗼-𝗺𝗮𝗿𝗸𝗲𝘁 𝗮𝗻𝗱 𝗽𝗿𝗼𝗱𝘂𝗰𝘁𝗶𝗼𝗻 𝗰𝗼𝘀𝘁𝘀? Just get in touch with us. {{𝗧𝗲𝗮𝗺 𝗦𝗵𝗮𝗺𝗮𝗻}}